Last Post: 04/03/2019 1:05:40 PM
Board Marks: 2
Posts Today: 0
Board Views Today: 3
Vericel Corporation. (NASDAQ: VCEL)
Vericel Corporation is the leader in developing patient-specific, expanded multicellular therapies for use in the treatment of patients with severe, chronic cardiovascular diseases. The company's proprietary cell-processing technology enables the manufacture of ixmyelocel-T, a patient-specific multicellular therapy expanded from a patient's own bone marrow and delivered directly to damaged tissues.
Company Website: http://www.aastrom.com/
Vericel Corporation is the leader in developing patient-specific, expanded multicellular therapies for use in the treatment of patients with severe, chronic cardiovascular diseases. The company's proprietary cell-processing technology enables the manufacture of ixmyelocel-T, a patient-specific multicellular therapy expanded from a patient's own bone marrow and delivered directly to damaged tissues.
Company Website: http://www.aastrom.com/
Vericel Corporation (VCEL) Research Links
Vericel Corporation (NASDAQ: VCEL) Stock Message Board
Post
Subject
Author
Posted On
